FBIO.US Fortress Biotech Inc

Healthcare Biotechnology USA Stocks
1.88 USD
Close of Nov 14, 2026
1.76 4.53
Market cap
USD 62.7M
P/E
0.7x
P/B
0.40x
ROE
86.7%
Dividend yield
1.06%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is FBIO.US undervalued?

Graham number

The Graham number of Fortress Biotech Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Fortress Biotech Inc fundamental analysis

No fundamental analysis for Fortress Biotech Inc yet.

Fortress Biotech Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Fortress Biotech Inc

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical foam for the treatment of les…

Full company profile